59 related articles for article (PubMed ID: 38611077)
1. HIVEC as an alternative option in non-muscle-invasive bladder cancer: Experiences from a high-volume center.
Kastner L; Rieger C; Pfister D; Schmautz M; Storz E; Heidenreich A
Urol Oncol; 2024 Aug; 42(8):245.e19-245.e26. PubMed ID: 38653592
[TBL] [Abstract][Full Text] [Related]
2. Safety and Efficacy of Immediate Hyperthermic Intravesical Chemotherapy Following Transurethral Resection of Bladder Tumour (I-HIVEC).
Wong CH; Ko IC; Leung DK; Yuen SK; Chan SY; Yee SC; Chiu PK; Ng CF; Teoh JY
Eur Urol Oncol; 2024 May; ():. PubMed ID: 38806344
[TBL] [Abstract][Full Text] [Related]
3. Interferon alfa in the treatment paradigm for non-muscle-invasive bladder cancer.
Lamm D; Brausi M; O'Donnell MA; Witjes JA
Urol Oncol; 2014 Jan; 32(1):35.e21-30. PubMed ID: 23628309
[TBL] [Abstract][Full Text] [Related]
4. Hyperthermic Intravesical Chemotherapy (HIVEC) Using Epirubicin in an Optimized Setting in Patients with NMIBC Recurrence after Failed BCG Therapy.
Blanc J; Ruggiero J; Lucca I; Arnold N; Kiss B; Roth B
Cancers (Basel); 2024 Apr; 16(7):. PubMed ID: 38611077
[TBL] [Abstract][Full Text] [Related]
5. Adjuvant Hyperthermic Intravesical Chemotherapy in Intermediate- and High-Risk Non-muscle Invasive Bladder Cancer.
Magalhães JC; Sousa M; Basto R; Fraga T; Gomes I; Fernandes C; Mariano M; Paulo J; Madeira P; Sousa G
Cureus; 2023 Sep; 15(9):e45672. PubMed ID: 37745737
[TBL] [Abstract][Full Text] [Related]
6. Long-term efficacy of hyperthermic intravesical chemotherapy for BCG-unresponsive non-muscle invasive bladder cancer.
Pijpers OM; Hendricksen K; Mostafid H; de Jong FC; Rosier M; Mayor N; de Jong JJ; Boormans JL
Urol Oncol; 2022 Feb; 40(2):62.e13-62.e20. PubMed ID: 34470725
[TBL] [Abstract][Full Text] [Related]
7. Comparison of hyperthermic intravesical chemotherapy and Bacillus Calmette-Guerin therapy in high-risk non-muscle invasive bladder cancer: a matched-pair analysis.
Pazir Y; Esmeray A; Caglar U; Erbin A; Ozgor F; Sarilar O; Akbulut F
Int Urol Nephrol; 2024 Mar; 56(3):957-963. PubMed ID: 37880493
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of hyperthermic intravesical chemotherapy (HIVEC) in patients with non-muscle invasive bladder cancer after BCG failure.
Pignot G; Baboudjian M; Lebacle C; Chamouni A; Lechevallier E; Irani J; Tillou X; Waeckel T; Monges A; Doisy L; Walz J; Gravis G; Mourey E; Duperron C; Masson-Lecomte A
World J Urol; 2023 Nov; 41(11):3195-3203. PubMed ID: 36811732
[TBL] [Abstract][Full Text] [Related]
9. Comparing adverse effects, short term outcomes, and cost implications of hyperthermic intravesical chemotherapy with Mitomycin-C and intravesical bacillus Calmette-Guerin instillation (Moscow-I strain) in the management of intermediate and high-risk nonmuscle invasive bladder cancer.
Thyavihally YB; Waigankar SS; Dev P; Asari A; Pednekar AP; Athikari N; Raut A; Khandekar A; Badlani N
Urol Ann; 2021; 13(4):424-430. PubMed ID: 34759657
[TBL] [Abstract][Full Text] [Related]
10. Device-assisted intravesical chemotherapy treatment for nonmuscle invasive bladder cancer: 2022 update.
Vartolomei MD; Ferro M; Roth B; Teoh JY; Gontero P; Shariat SF
Curr Opin Urol; 2022 Sep; 32(5):575-583. PubMed ID: 35749398
[TBL] [Abstract][Full Text] [Related]
11. Intravesical gemcitabine as bladder-preserving treatment for BCG unresponsive non-muscle-invasive bladder cancer. Results from a single-arm, open-label study.
Hurle R; Casale P; Morenghi E; Saita A; Buffi N; Lughezzani G; Colombo P; Contieri R; Frego N; Guazzoni G; Lazzeri M
BJUI Compass; 2020 Sep; 1(4):126-132. PubMed ID: 35474942
[TBL] [Abstract][Full Text] [Related]
12. Intravesical gemcitabine for non-muscle invasive bladder cancer.
Han MA; Maisch P; Jung JH; Hwang JE; Narayan V; Cleves A; Hwang EC; Dahm P
Cochrane Database Syst Rev; 2021 Jun; 6(6):CD009294. PubMed ID: 34125951
[TBL] [Abstract][Full Text] [Related]
13. Required efficacy for novel therapies in BCG-unresponsive non-muscle invasive bladder cancer: Do current recommendations really reflect clinically meaningful outcomes?
Wettstein MS; Naimark D; Hermanns T; Herrera-Caceres JO; Ahmad A; Jewett MAS; Kulkarni GS
Cancer Med; 2020 May; 9(10):3287-3296. PubMed ID: 32163677
[TBL] [Abstract][Full Text] [Related]
14. Heated Intravesical Chemotherapy: Biology and Clinical Utility.
Tan WP; Longo TA; Inman BA
Urol Clin North Am; 2020 Feb; 47(1):55-72. PubMed ID: 31757301
[TBL] [Abstract][Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
